Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 6Recruiting 3Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Other hematologic neoplasm 4Thoracic 3Lymphoid 3Other solid neoplasm 2Other 2Genitourinary 2Other neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 5Trastuzumab Cardiotoxicity 1Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Heart Diseases 1Cardiotoxicity 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Exercise Test × Breast × Clear all
NCT01186367 2025-02-10

Excite

Memorial Sloan Kettering Cancer Center

Phase NA Completed
174 enrolled 11 charts
Breast

Breast Neoplasms

NCT03510689 2024-10-16

Gene-HEART

Abramson Cancer Center at Penn Medicine

Completed
79 enrolled
BreastGynecologic

Breast Neoplasms, Heart Diseases, Hereditary Breast and Ovarian Cancer Syndrome

NCT02615054 2024-04-11

Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors

Memorial Sloan Kettering Cancer Center

Completed
58 enrolled
Breast

Trastuzumab Cardiotoxicity

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT01725633 2023-04-06

Breast Mets

Memorial Sloan Kettering Cancer Center

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

NCT02702830 2019-04-26

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

Wake Forest University Health Sciences

Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡